These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 580991

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
    Watanabe S, Shimizu Y, Teramatsu T, Murachi T, Hino T.
    J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
    [Abstract] [Full Text] [Related]

  • 23. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Urokinase immobilized on medical polymeric materials: fundamental and clinical studies.
    Ohshiro T, Kosaki G.
    Artif Organs; 1980 Feb; 4(1):58-4. PubMed ID: 6989347
    [Abstract] [Full Text] [Related]

  • 28. [Fibrinolytic therapy in deep venous thrombosis of the upper and lower extremity].
    Kriessmann A, Theiss W, Lutilsky L, Wirtzfeld A, Seifert W, Grünberg G.
    Fortschr Med; 1977 Apr 07; 95(13):858-66. PubMed ID: 844772
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Apr 07; 119(4):475-80. PubMed ID: 16828495
    [Abstract] [Full Text] [Related]

  • 31. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
    Ueno T, Kobayashi N, Maekawa T.
    Thromb Haemost; 1979 Oct 31; 42(3):885-94. PubMed ID: 505403
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Heparin and urokinase interactions in the fibrinolytic system].
    Villaverde CA, Badimón L, Badimón JJ, Valdecasas FG.
    Arch Farmacol Toxicol; 1979 Dec 31; 5(3):268-9. PubMed ID: 397804
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
    Zamarron C, Lijnen HR, Van Hoef B, Collen D.
    Thromb Haemost; 1984 Aug 31; 52(1):19-23. PubMed ID: 6495259
    [Abstract] [Full Text] [Related]

  • 37. Effect of urokinase on fibrinolysis and fibrinogenolysis.
    Matsuo O, Nishida Y, Akazawa K, Mihara H.
    Jpn J Physiol; 1982 Aug 31; 32(5):879-83. PubMed ID: 6759739
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G, Noring R, Klempner MS.
    Biochem Biophys Res Commun; 1996 Feb 27; 219(3):690-5. PubMed ID: 8645243
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [In vitro measurement of fibrinolysis by urokinase].
    Senf L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Feb 27; 108(6):819-21. PubMed ID: 6176506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.